|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
ɳ����ԭ�� |
|
�������ɳ����ԭ�� |
|
��Ҫ��Ĥ���� |
|
�ٷ��ͳ�����Ӧ |
| ��������������� | |
|
��ʿǿ���� |
|
��ȫ����У |
| PubMed | |
|
Article by |
|
Article by |
ɳ����ԭ���Ⱦ���ߺ�DNA���������ЧӦ
��ʿǿ����, ��ȫ����У
���ҽ�ƴ�ѧ��ҽԺƤ���Բ���
ɳ����ԭ����ɳ�ۺ��Դ�����������Ҫ��ԭ��֮һ,ɳ����ԭ���Ⱦ��ʹHIV-1���״�����ɳ����ԭ���Ⱦ�������շ����屣���Ե���Һ���ߺ�ϸ������,�ڳ��θ�Ⱦ,��ϸ�����߶����ǿ�������Ҫ��������;���ڼ̷���Ⱦ,���������߸߶�����Th1��CD4+Tϸ��,�����յ��ٷ��ͳ�����Ӧ����չ������Ԥ��ɳ����ԭ���Ⱦ����Ч;����
[2] Puolakkainen M, Makela PH. Vaccination against infections by Chlamydia pneumonia. C R Acad Sci ��, 1999,322(11):973-978.
[3] Yang X, Brunham RC. T lymphocyte immunity in host defense against Chlamydia trachomatis and its implication for vaccine development. Can J Infect Dis, 1998,9:99-109.
[4] Perry LL, Su H, Feilzer K, et al. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-y-mediated inhibition. J I mmunol, 1999,162(6):3541-3548.
[5] Williams DM, Grubbs BG, Pack E, et al. Humoral and cellular immunity in secondary infection due to murine Chlamydia tracoomatis. Infect Immun, 1997,65(7):2876-2882.
[6] Su H, Caldwell HD. CD4+T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun, 1995,63(9):3302-3308.
[7] Rottenberg ME, Gigliotti Rothfuchs A, Gigliotti D, et al. Regulation and role of IFN-�� in the innate resistance to infection with Chlamyddia pneumoniae. J Immunol, 2000,164(9):4812-4818.
[8] Vuola JM, Puurula V, Anttila M, et al. Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge. Infect Immun,2000,68(2):960-964.
[9] Yang X, Gartner J, Zhu L, et al. IL-10 gene knockout mice show enhanced Thl-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J Imamunol, 1999, 162(2):1010-1017.
[10] Huang J, Wang MD, Lenz S, et al. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue. J Immunolgy, 1999,162(4):2217-2226.
[11] Lampe ME, Wilson CB, Bevan MJ, et al. Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun, 1998,66(11):5457-5461.
[12] Penttila JM, Anttila M, Varkila K, et al. Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology, 1999,97(3):490-496.
[13] Batteiger BE. The major outer membrane protein of a single Chlamydia trachomatis serovar-specific epitope. Infect Immun, 1996, 64(2):542-547.
[14] Pal S, Theodor I, Peterson EM, et al. Monoclonal immunoglobuhn A antibody to the major outer membrane protein of the Chlamydia tmchomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine, 1997,15(5):575-582.
[15] Yang X, Brunham RC. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamdia trachomatis(mouse pneumonitis) lung inffection. J Immunol,1998,161(3):1439-1446.
[16] Sanchez-Campillo M, Bini L, Comanducci M, et al. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis,1999,20(11):2269-2279.
[17] Liu MA. Overview of DNA vaccines. Mm N Y Acad Sci, 1995,772:15-20.
[18] Donnelly JJ, Ulmer JB, Shiver JW, et al. DNA vaccines. Annu Rev Immunol, 1997,15:617-648.
[19] Barry MA, Lai WC, Johnston SA, et al. Protection against mycoplasma infection using expression-library immunization. Nature, 1995,377(6550):632-635.
[20] Stagg.AJ. Vaccines against chlamydia:approaches and progress. Mol Med Today, 1998,4(4):166-173.
[21] Zhang D, Yang X, Berry J, et al. DNA vaccination with the major outermembrane protein gene induces acquired immunity to Chlamydia trachomatis(mouse pneumonitis) infection. J Infect Dis, 1997, 176(4):1035-1040.
[22] Brunham RC, Zhang D. Transgene as vaccine for chlamydia.Am Heart J,1999, 138(5 Pt 2):S519-522.
[23] Zhang DJ, Yang X, Shen C, et al. Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Ctlamydia trachomatis mouse pneumonitis agent. Immunology, 1999,96(2):314-321.
[24] Pal S, Barnhart KM, Wei Q, et al. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge.Vaccine, 1999, 17(5):459-465.
[25] Su H, Messer R, Whitmire W, et al. Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response:implications for development of live attenuated chlamydial vaccine strains. Infect Immun, 2000,68(1):192-196.
[26] Svanholm C, Bandholtz L, Castanos-Velez E, et al. Protective DNA immmunization against Chlamydia pneumoniae. Scand J Immunol, 2000, 51(4):345-353.